Página 2 - Melhores Leiomiossarcoma médicos - TOP-62 médicos

O médico formou-se na Faculdade de Medicina da Universidade de Ancara e completou a residência em medicina interna na Faculdade de Medicina de Ancara GATA. Especializando-se em oncologia médica e hematologia, o médico completou uma bolsa clínica nos EUA. Pioneiro na Turquia, o médico fez parte da equipe que realizou o primeiro transplante de medula óssea no país. O médico atuou como professor visitante em instituições de prestígio em Londres e Suíça. Detentor do Certificado Europeu de Oncologia Médica, o médico é membro fundador tanto da Sociedade Turca de Oncologia Médica quanto do Grupo Oncológico Turco. O foco clínico inclui câncer de mama, gastrointestinal, pulmão, linfomas e mieloma.<\/p>

O Dr. Tahsin Ozadli é especialista em oncologia médica, com ampla formação no Hospital de Oncologia de Ancara.

• Especializar-se em cancros do pulmão, esófago e estômago
• Trabalhar na Clínica de Oncologia Médica do Hospital de Oncologia de Ancara
• Publicar investigação em oncologia – consultar o perfil no Google Scholar

A Prof.ª Elke Jaeger chefia a Oncologia e Hematologia no Nordwest – nomeada uma das melhores oncologistas da Alemanha pela Focus.

• 39 anos de experiência com especialização em oncologia
• Mais de 1.100 procedimentos realizados
• Professora de Oncologia Interdisciplinar
• Membro do comité de especialistas da EORTC

O Dr. Alemdar é especialista em oncologia médica com ampla formação na Universidade Akdeniz, uma instituição líder na Turquia.

• Certificado em oncologia médica desde 2018
• Mais de 15 anos de experiência em medicina interna e oncologia
• Trabalhou no Hospital Universitário Akdeniz, conhecido pelos seus tratamentos oncológicos avançados

O Prof. Dr. Ozcan Yildiz possui mais de uma década de pesquisa especializada e publicações em casos oncológicos complexos. Ele atende pacientes no Hospital Universitário Medipol Mega.

• Autor de numerosos estudos sobre tumores raros, como cancros neuroendócrinos e neuroectodérmicos
• Especialista no manejo de síndromes paraneoplásicas relacionadas ao cancro e apresentações incomuns
• Experiente na gestão de efeitos secundários complexos de terapias oncológicas avançadas
• Membro de redes de pesquisa oncológica profissional, contribuindo para a literatura médica

O Dr. Levin lidera o programa de sarcoma pediátrico no Sourasky Medical Center e estudou no Rizzoli Orthopaedic Institute, na Itália, líder mundial na área.

• Mais de 30 anos de experiência em hematologia e oncologia pediátrica
• Especializar-se em tumores ósseos e sarcomas de tecidos moles em crianças
• Pediatra sênior no Hospital Infantil Dana, em Tel Aviv
• Diretor do departamento de hematologia-oncologia pediátrica do Sourasky
• Membro da Sociedade Israelense de Hematologia e Oncologia Pediátrica

O Prof. Köstler é um distinto oncologista médico especializado em terapias-alvo, com mais de 20 anos de experiência em cancros da mama e ginecológicos na Wiener Privatklinik.

• Professor Associado na Universidade Médica de Viena
• Chefe Adjunto da Divisão Clínica de Oncologia
• Especialista em desenvolvimento de biomarcadores e biologia tumoral
• Publicar em revistas internacionais de oncologia de referência

O Professor Keil é especialista em imagiologia seccional e radiologia intervencionista, aplicando técnicas avançadas como RM, TC e ecografia para um planeamento preciso de diagnósticos e tratamentos.

• Licenciar-se com distinção pela Julius-Maximilians-Universität Würzburg
• Liderar a Clínica de Radiologia Diagnóstica e Intervencionista do Hospital Universitário de Aachen
• Ser atualmente Médico-Chefe no Hospital Académico de Solingen
• Ser especialista em RM e TC para padrões de doenças complexas

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Mais de 30 anos em imunologia – O Dr. Jaunalksne é especialista em viroterapia, uma abordagem de ponta para a modulação do sistema imunitário.

• Chefiar o Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Licenciar-se no Instituto Médico de Riga com estágio em Medicina Interna
• Focar-se em tratamentos imunológicos inovadores

O Prof. Adjunto Nail Paksoy especializa-se em Leiomiossarcoma no Hospital Medipol Bahcelievler, com Certificação da ESMO em Oncologia Médica.

• Publicar pesquisas sobre quimioterapia de dose alta para o Sarcoma de Ewing
• Sub-investigador em 8 ensaios clínicos internacionais para cancros avançados
• Especialização em Oncologia Médica no Instituto de Oncologia da Universidade de Istambul
• Membro da ESMO com experiência em tratamentos de sarcoma

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.